KSC Equity Snapshot
001360 Weekly Equity Report
SAMSUNG PHARM. Co., LTD.
What the company does
SAMSUNG PHARM. Co., LTD. manufactures and sells pharmaceutical products in South Korea. It offers prescription medicines, such as anticancer immunotherapy, antipyretic analgestic and antiinflammatory, antiobesity, hypotensive, antiarteriosclerotic, digestive organs, antophlegms, enzymes, ostepoposis, and transfusion agents, as well as skeletal muscle relaxants, anti-spastic, enzyme, mixed vitamins, antibiotics, and others. The company also provides medicines for the digestive system, medicines for liver disorders, medicines for the circulation system, cold medicines, nutritional supplements, health tonics, antophlegm agents, and others, as well as quasi-medicines, cold medicines, vitamins and energy drinks, and functional foods. The company was founded in 1929 …
What the weekly tape is saying
001360 closed the latest completed week at 1,376 KRW. The 4-week return is -19.1% and the 12-week return is -26.9%. Trend Signal is inactive, Market Dynamics is -1.32. Setup signature: Risk-first tape with a 8/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 1,732 KRW
- Vs Trend Line
- -20.6%
- Fair Value
- 1,815 KRW
- Vs Fair Value
- -24.2%
- 52W High
- 2,320 KRW
- 52W Low
- 1,296 KRW
- Drawdown
- -40.7%
- Range Position
- 7.8%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 32
- 52W Active Breadth
- 61.5%
- Sector Scope
- KR Healthcare
- Sector Rank
- 40 of 63
- Sector Percentile
- 37.1%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
KR Healthcare
- Tracked Peers
- 63
- 4W Rank
- 54 of 63
- Avg 1W
- -1.0%
- Avg 4W
- -12.7%
- Trend Breadth
- 1.6%
- Positive MD
- 6.3%
KR Drug Manufacturers - Specialty & Generic
- Tracked Peers
- 44
- 4W Rank
- 38 of 44
- Avg 1W
- -1.3%
- Avg 4W
- -12.9%
- Trend Breadth
- 2.3%
- Positive RS
- 0.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -1.32
- 4W MD Change
- -2458.7%
- Relative Strength
- -56.18
- 4W RS Change
- -22.5%
- Expectation
- Negative
- Probability
- 40.52%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 2.5M
- 13W Average
- 6.4M
- 52W Average
- 6.7M
- Vs 13W
- 0.4x
- Vs 52W
- 0.4x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 6.8%
- 52W Volatility
- 7.6%
- Upside Weeks
- 20
- Downside Weeks
- 32
- Downside Breadth
- 61.5%
- Avg Gain / Loss
- 6.0% / -4.3%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- KSC
- Country
- KR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- KRW
- Market Cap
- 139.8B
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 1,376 KRW | -1.3% | 1,732 KRW | 1,815 KRW | -1.32 | -56.18 | 2.5M | Off |
| 5 Jun 2026 | 1,394 KRW | -8.0% | 1,735 KRW | 1,825 KRW | -1.19 | -56.85 | 3.2M | Off |
| 29 May 2026 | 1,515 KRW | -8.2% | 1,740 KRW | 1,834 KRW | -0.97 | -55.73 | 3.7M | Off |
| 22 May 2026 | 1,651 KRW | -2.9% | 1,740 KRW | 1,844 KRW | -0.58 | -48.92 | 3.9M | On |
| 15 May 2026 | 1,701 KRW | -6.8% | 1,736 KRW | 1,855 KRW | -0.05 | -45.84 | 6.2M | On |
| 8 May 2026 | 1,825 KRW | -10.1% | 1,731 KRW | 1,860 KRW | 0.19 | -42.80 | 7.0M | On |
| 1 May 2026 | 2,030 KRW | -6.7% | 1,723 KRW | 1,864 KRW | 0.35 | -28.76 | 9.6M | On |
| 24 Apr 2026 | 2,175 KRW | 16.9% | 1,709 KRW | 1,868 KRW | 0.31 | -23.18 | 24.2M | On |
| 17 Apr 2026 | 1,861 KRW | 3.0% | 1,690 KRW | 1,870 KRW | 0.16 | -32.05 | 4.6M | On |
| 10 Apr 2026 | 1,807 KRW | 0.7% | 1,684 KRW | 1,876 KRW | 0.17 | -31.18 | 8.0M | On |
| 3 Apr 2026 | 1,794 KRW | -5.2% | 1,681 KRW | 1,881 KRW | 0.32 | -26.45 | 3.8M | On |
| 27 Mar 2026 | 1,892 KRW | 0.5% | 1,676 KRW | 1,886 KRW | 0.47 | -24.16 | 4.0M | On |
| 20 Mar 2026 | 1,883 KRW | 0.3% | 1,665 KRW | 1,889 KRW | 0.65 | -29.69 | 2.2M | On |
| 13 Mar 2026 | 1,877 KRW | 0.7% | 1,655 KRW | 1,892 KRW | 0.92 | -26.98 | 3.0M | On |